Use of CLL1 and CD45RA As Biomarkers for Leukemia Stem Cells in Acute Myeloid Leukemia Re-Induction Therapy Decision Making

被引：0
|
作者：
Lin, Hong [1 ]
Lee, Christina [2 ]
Tufano, Danielle Marie [3 ]
Liu, Suhu [4 ]
机构：
[1] Stony Brook Univ Hosp, Dept Pathol, Stony Brook, NY USA
[2] Weill Cornell Med, New York, NY USA
[3] Stony Brook Univ Hosp, Stony Brook, NY USA
[4] Stony Brook Univ Hosp, Dept Med, Stony Brook, NY USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-182546
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] STUDY OF CD45RA AS A MARKER OF LEUKEMIC STEM CELL AND CHARACTERIZATION OF ITS QUIESCENCE IN ACUTE MYELOID LEUKEMIA
    Lainez, Gonzalez Daniel
    Serrano, Lopez Juana
    Blas, Lopez Carlos
    Castano, Bonilla Tamara
    Salgado, Sanchez Rocio Nieves
    Llamas, Sillero Pilar
    Alonso, Dominguez Juan Manuel
    HAEMATOLOGICA, 2020, 105 : 43 - 44
  • [2] Management of Refractory Acute Myeloid Leukemia: Re-induction Therapy or Straight to Transplantation?
    Feldman, E. J.
    Gergis, Usama
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2012, 7 (01) : 74 - 77
  • [3] Management of Refractory Acute Myeloid Leukemia: Re-induction Therapy or Straight to Transplantation?
    E. J. Feldman
    Usama Gergis
    Current Hematologic Malignancy Reports, 2012, 7 : 74 - 77
  • [4] Induction of apoptosis of myeloid leukemia with CSC17.1, a unique monoclonal antibody targeting CD45RA
    Tesi, R. J.
    Tran, H.
    Christensen, J.
    Morales, J.
    Karimi, M.
    Sagy, M.
    Palath, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] Re-induction therapy in patients with acute myeloid leukemia not in complete remission after the first course of treatment
    Fu, Weijia
    Hu, Yue
    Lu, Guihua
    Xu, Lili
    Gao, Lei
    Chen, Jie
    Chen, Li
    Tang, Gusheng
    Ni, Xiong
    Yang, Jianmin
    ANNALS OF HEMATOLOGY, 2023, 102 (02) : 329 - 335
  • [6] Re-induction therapy in patients with acute myeloid leukemia not in complete remission after the first course of treatment
    Weijia Fu
    Yue Hu
    Guihua Lu
    Lili Xu
    Lei Gao
    Jie Chen
    Li Chen
    Gusheng Tang
    Xiong Ni
    Jianmin Yang
    Annals of Hematology, 2023, 102 : 329 - 335
  • [7] Re-induction therapy decisions based on day 14 bone marrow biopsy in acute myeloid leukemia
    Morris, Tod A.
    DeCastro, Carlos M.
    Diehl, Louis F.
    Gockerman, Jon P.
    Lagoo, Anand S.
    Li, Zhiguo
    Moore, Joseph O.
    Rizzieri, David A.
    Rao, Arati V.
    LEUKEMIA RESEARCH, 2013, 37 (01) : 28 - 31
  • [8] Re-induction therapy in adult patients with acute myeloid leukemia with ≤20 % blasts: A retrospective cohort study
    Kannan, Kavya K.
    Vellanki, Paz
    Isom, Scott
    Tawfik, Bernard
    Winter, Allison
    Klepin, Heidi D.
    Ellis, Leslie R.
    Bhave, Rupali Roy
    Howard, Dianna
    Manuel, Megan
    Dralle, Sarah
    Lyerly, Susan
    Powell, Bayard L.
    Pardee, Timothy S.
    LEUKEMIA RESEARCH, 2021, 111
  • [9] Re-Induction Therapy Decisions Based on Day 14 Bone Marrow Biopsy in Acute Myeloid Leukemia
    Morris, Tod A.
    Rizzieri, David A.
    de Castro, Carlos M.
    Diehl, Louis F.
    Gockerman, Jon P.
    Lagoo, Anand S.
    Moore, Joseph O.
    Rao, Arati V.
    BLOOD, 2011, 118 (21) : 1532 - 1533
  • [10] Efficacy and safety of CAR-T therapy targeting CLL1 in patients with extramedullary diseases of acute myeloid leukemia
    Zhao, Yifan
    Bai, Xue
    Guo, Shujing
    Zhang, Xiaomei
    Liu, Jile
    Zhao, Mohan
    Xie, Tianle
    Meng, Haotian
    Zhang, Yu
    He, Xiaoyuan
    Zhao, Mingfeng
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
12345